A new once-daily dose of the antidepressant Trazodone helped insomnia and depression in recent clinical trial. The manufacturer Labopharm plans to apply for permission to sell the new formulation later this year.
Read moreDr. Philip Barter of the Heart Research Institute of Sydney, Australia, presented an update of the disappointing ILLUMINATE clinical drug... Read more »
Way back in 1995, doctors in the US and patients with diabetes had a new option to treat type 2 diabetes: a drug of a different kind from... Read more »
Another diabetes drug, dapagliflozin, may soon be available to treat type 2 diabetes. Dapagliflozin is the first in a new class of diabetes... Read more »
In the mid 1990s a new class of medicines arrived that revolutionized the treatment of erectile dysfunction. These medicines are known as... Read more »
Sodium-glucose transporter-2 (SGLT2) is the name of a "transporter protein" in the kidneys that has become a hot topic in diabetes... Read more »
Labopharm, the manufacturer of the once-a-day antidepressant Trazodone, is enrolling patients in a national clinical trial. The once-a-day formula is... Read more »
Wake Forest University researchers say that a commonly used class of drugs may slow down mental and physical function in seniors. Anticholingeric... Read more »
Doctors at Columbia University Medical Center have discovered the molecular pathways that pain travels and may also have found a way to turn off that... Read more »
Researchers at Monash/Bayer have found a drug that may reduce the risk of hypertension and heart attacks by improving blood flow in diseased... Read more »
Source: ADAM Encyclopedia
Trazodone is an antidepressant medication. Trazodone overdose occurs when someone accidentally or intentionally takes more than the normal or... Read more »